Dark

Check out our Level2View

SXTC
China SXT Pharmaceuticals, Inc.
stock NASDAQ

At Close

Mar 13, 2026 3:59:30 PM EDT

1.89USD-11.268%(-0.24)55,321

0.00Bid 0.00Ask 0.00Spread

Pre-market

Mar 13, 2026 8:11:30 AM EDT

2.06USD-3.188%(-0.07)200

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 20, 2022

10:45AM EST China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4 GlobeNewswire Inc

Jan 18, 2022

02:33PM EST Mid-Afternoon Market Update: Dow Dips 500 Points; NeuroMetrix Shares Spike Higher Benzinga

12:09PM EST Mid-Day Market Update: Nasdaq Tumbles 250 Points; Activision Blizzard Shares Jump Benzinga

06:51AM EST China SXT Pharmaceuticals, Inc. Prices $3.5M Underwritten Public Offering Of Ordinary Shares; 19.8M Shares At $0.18/Share Benzinga

06:48AM EST China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten GlobeNewswire Inc

Jan 14, 2022

05:43PM EST China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten GlobeNewswire Inc

02:34PM EST China SXT Pharmaceuticals Says Adds Newly Developed Kuihuapan, Zhudanfen Advanced TCMP Products, Announces Expected Continuous Growth Of Production Capacity Of Luxuejin Benzinga

02:31PM EST Advanced TCMP Products, and Announces the Expected Continuous Growth of Its Production Capacity of Luxuejin PR Newswire

Dec 16, 2021

08:07AM EST China SXT Pharmaceuticals, Inc. Receives Nasdaq Notification Letter Regarding Bid Price Deficiency Benzinga

08:06AM EST China SXT Pharma Gets Nasdaq Notification Letter Regarding Bid Price Deficiency RTTNews

08:02AM EST China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding PR Newswire

Oct 18, 2021

08:12AM EDT China SXT Pharma Obtained New Pharma Manufacturing Permit, Passed Its Good Manufacturing Process Compliance Inspection Benzinga

08:12AM EDT China SXT Pharma Says Gets New Pharmaceutical Manufacturing Permit, Passes Its GMP Compliance-Inspection RTTNews

08:01AM EDT China SXT Pharmaceuticals, Inc. Obtained a New Pharmaceutical Manufacturing PR Newswire

Oct 7, 2021

08:24AM EDT The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results Benzinga

Oct 5, 2021

08:01AM EDT The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout Benzinga

Jul 19, 2021

10:21AM EDT Mid-Morning Market Update: Markets Open Lower; AutoNation Profit Beats Estimates Benzinga

Feb 22, 2021

05:14AM EST China SXT Pharmaceuticals Trading Today on 1:4 Reverse Share Split Benzinga

Feb 19, 2021

08:13AM EST China SXT Pharmaceuticals, Inc. Announces 1 For 4 Reverse Share Split, Effective Feb. 22 Benzinga

08:05AM EST China SXT Pharmaceuticals Announces 1 For 4 Reverse Share Split RTTNews

08:01AM EST China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split PR Newswire

Feb 18, 2021

08:14AM EST The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga

Feb 17, 2021

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

Sep 9, 2020

09:02AM EDT NASDAQ Granted China SXT Pharmaceuticals, Inc. 180-Day Extension to Regain PR Newswire

Share